Public Health and Economic Benefits of Influenza Vaccination of the Population Aged 50 to 59 Years without Risk Factors for Influenza Complications in Mexico: A Cross-Sectional Epi...

by Miguel Betancourt-Cravioto, Jorge Abelardo Falcón-Lezama, Rodrigo Saucedo-Martínez, Myrna María Alfaro-Cortés, Roberto Tapia-Conyer
Published 2021-02-01

A Call for a Reform of the Influenza Immunization Program in Mexico: Epidemiologic and Economic Evidence for Decision Making

by Roberto Tapia-Conyer, Miguel Betancourt-Cravioto, Alejandra Montoya, Jorge Abelardo Falcón-Lezama, Myrna María Alfaro-Cortes, Rodrigo Saucedo-Martínez
Published 2021-03-01

Influenza in the school-aged population in Mexico: burden of disease and cost-effectiveness of vaccination in children

by Jorge Abelardo Falcón-Lezama, Rodrigo Saucedo-Martínez, Miguel Betancourt-Cravioto, Myrna María Alfaro-Cortes, Roberto Isaac Bahena-González, Roberto Tapia-Conyer
Published 2020-03-01